CD59 complement

As an important target for therapeutic antibody exploration and clinical trial, CD59 complement has become the global research hotspot, due to the importance in the regulation of complement activation. With advanced technologies and long-term scientific expertise, Creative Biolabs has successfully developed a series of innovative and effective therapeutic antibodies for related diseases. Now, we are proud to offer a full range of formulation development services for complement drug discovery.